2017-11 | Association between non-alcoholic fatty liver disease and cancer incidence rate | 안지현 |
2018-03 | Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study | 안지현 |
2019-09 | The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the disease | 안지현 |
2017-06 | Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion | 안지현 |
2017-03 | Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma | 안지현 |
2018-06 | Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion | 안지현 |
2020-07 | Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases | 안지현 |
2020-08 | Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma | 안지현 |
2017-09 | Current status and strategies for hepatitis B control in Korea | 안지현 |
2018-06 | The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection | 안지현 |
2018-05 | Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion A Randomized Clinical Trial | 안지현 |
2020-03 | Hepatocyte-Specific Magnetic Resonance Imaging-Based Assessment of Indeterminate Hepatic Nodules in the Liver Transplant Evaluation of Patients With Cirrhosis | 안지현 |
2017-11 | Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response. | 안지현 |
2018-04 | Histological expression of methionine adenosyl transferase (MAT) 2A as a post-surgical prognostic surrogate in patients with hepatocellular carcinoma | 안지현 |
2019-07 | Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes | 안지현 |
2017-09 | Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial | 안지현 |
2017-04 | MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma | 안지현 |
2020-04 | Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound | 안지현 |
2019-07 | A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma | 안지현 |
2020-07 | Stereotactic body radiation therapy for small (˂= 5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial | 안지현 |
2017-01 | Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial. | 안지현 |
2017-10 | Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma | 안지현 |
2021-01 | Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study | 안지현 |